These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6358066)

  • 1. Kinetics of cutaneous drug penetration.
    Franz TJ
    Int J Dermatol; 1983 Nov; 22(9):499-505. PubMed ID: 6358066
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cutaneous penetration].
    Jamoulle JC
    Ann Dermatol Venereol; 1988; 115(5):627-40. PubMed ID: 3058009
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption.
    Wester RC; Maibach HI
    Drug Metab Rev; 1983; 14(2):169-205. PubMed ID: 6341024
    [No Abstract]   [Full Text] [Related]  

  • 4. Modest but increased penetration through damaged skin: an overview of the in vivo human model.
    Gattu S; Maibach HI
    Skin Pharmacol Physiol; 2011; 24(1):2-9. PubMed ID: 20588085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro estimates of topical bioavailability.
    Ando HY; HO NF; Higuchi WI
    J Pharm Sci; 1977 May; 66(5):755-7. PubMed ID: 874771
    [No Abstract]   [Full Text] [Related]  

  • 6. A multiple-pathway model for the diffusion of drugs in skin.
    Lee AJ; King JR; Rogers TG
    IMA J Math Appl Med Biol; 1996 Jun; 13(2):127-50. PubMed ID: 8671583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of drug disposition kinetics in skin and plasma following topical administration.
    Guy RH; Hadgraft J
    J Pharm Sci; 1984 Jul; 73(7):883-7. PubMed ID: 6470948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration properties and safety aspects of topically applied products.
    Fluhr J; Lademann J
    Skin Pharmacol Physiol; 2008; 21(6):293. PubMed ID: 18997482
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of drug concentration in blood after topical application.
    Hori M; Ito Y
    Curr Probl Dermatol; 1995; 22():146-51. PubMed ID: 7587316
    [No Abstract]   [Full Text] [Related]  

  • 10. Mathematical and pharmacokinetic modelling of epidermal and dermal transport processes.
    Anissimov YG; Jepps OG; Dancik Y; Roberts MS
    Adv Drug Deliv Rev; 2013 Feb; 65(2):169-90. PubMed ID: 22575500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced absorption through damaged skin: an overview of the in vitro human model.
    Gattu S; Maibach HI
    Skin Pharmacol Physiol; 2010; 23(4):171-6. PubMed ID: 20185974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin as an active metabolizing barrier I: Theoretical analysis of topical bioavailability.
    Ando HY; Ho NF; Higuchi WI
    J Pharm Sci; 1977 Nov; 66(11):1525-8. PubMed ID: 915724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the human skin barrier--towards a better understanding of dermal absorption.
    Jepps OG; Dancik Y; Anissimov YG; Roberts MS
    Adv Drug Deliv Rev; 2013 Feb; 65(2):152-68. PubMed ID: 22525516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of skin penetration.
    Cooper ER
    J Pharm Sci; 1976 Sep; 65(9):1396-7. PubMed ID: 966163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo methods for the assessment of topical drug bioavailability.
    Herkenne C; Alberti I; Naik A; Kalia YN; Mathy FX; Préat V; Guy RH
    Pharm Res; 2008 Jan; 25(1):87-103. PubMed ID: 17985216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related percutaneous penetration part 1: skin factors.
    Konda S; Meier-Davis SR; Cayme B; Shudo J; Maibach HI
    Skin Therapy Lett; 2012 May; 17(5):1-5. PubMed ID: 22622279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vehicle effects in percutaneous absorption.
    Idson B
    Drug Metab Rev; 1983; 14(2):207-22. PubMed ID: 6341025
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transdermal therapeutics].
    Touitou E; Menczel E
    Harefuah; 1986 Apr; 110(7):356-9. PubMed ID: 3089890
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of bioavailability: measurement of absorption through skin in vitro.
    Hotchkiss SA
    Curr Protoc Toxicol; 2001 May; Chapter 5():Unit 5.1.1-14. PubMed ID: 20949434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A calculation of percutaneous drug absorption--I. Theoretical.
    Kubota K; Ishizaki T
    Comput Biol Med; 1986; 16(1):7-19. PubMed ID: 3948495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.